Marina Biotech, Inc. Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.59M 216M |
---|---|---|---|---|---|
Net income 2021 | -6M -500M | Net income 2022 | -2M -167M | EV / Sales 2021 | - |
Net Debt 2021 | 6.59M 548M | Net Debt 2022 | 8.55M 712M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.11
x | P/E ratio 2022 |
-0.69
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 88.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | 43 | 07/20/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles L. Rice
BRD | Director/Board Member | 59 | 10/20/10 |
Chief Operating Officer | 43 | 07/20/07 |
1st Jan change | Capi. | |
---|---|---|
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |